A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease
Abroad (travel likely)RecruitingPHASE3
Conditions
Atherosclerotic Cardiovascular Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fuwai Hospital, CAMS&PUMC, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Kefei Dou)Contact: Principal Investigator (Xiao Wang)
Study leads
Kefei Dou
Principal Investigator
Chinese Academy of Medical Sciences, Fuwai Hospital
Xiao Wang
Study Director
Chinese Academy of Medical Sciences, Fuwai Hospital